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The story of cell death began with the origins of cell biology, including important observations by Elie (Ilya) Metchnikoff, who 
realized that phagocytes engulfed dying cells. Most of the early studies were observational. By the middle of the 20th C, researchers 
were beginning to explore how cells died, had recognized that cell death was a physiologically controlled process, that the most 
common mode of death (“shrinkage necrosis”, later apoptosis) was tightly controlled, and were speculating whether lysosomes 
were “suicide bags”. Just prior to 1990 several discoveries led to rapid expansion of interest in the field and elucidation of the 
mechanisms of apoptosis. Closer to the beginning of the 21st C comprehensive analysis of the molecules that controlled and ef-
fected apoptosis led to the conclusion that autophagic processes were linked to apoptosis and could serve to limit or increase cell 
death. Today, realizing that knowledge of the components of cell death has not yet produced pharmaceuticals of therapeutic value, 
research is turning to questions of what metabolic or other mechanisms indirectly control the activation or suppression of the cell 
death positive feedback loop. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
Key Words: programmed cell death, apoptosis, caspase, history, autophagy, lysosomes.
In one sense, the story of cell death has some 
relationship to the Ukraine. Cell death plays a major 
role in development, homeostasis, and pathology but, 
although dying cells were recognized almost as soon 
as techniques permitted the examination of cells, its 
importance was largely underestimated because dying 
cells were so rarely seen. They are rarely seen because, 
while the newly synthesized DNA of a dividing cell can 
be labeled and that division can be identified as long 
as the cell survives, perhaps for many years, a dying 
cell is identifiable for 20 minutes to one hour, after 
which it is gone. It is gone because, most typically, 
it has been consumed by a phagocytic cell or phago-
cyte. Phagocytes were of course first described and 
documented — against considerable disbelief — 
by one of The Ukraine’s gifts to world science, Ilya (Elie) 
Metchnikoff. In fact, through the history of the field, 
the story of cell death pops up periodically as a factor 
in our understanding of cell biology.
In the mid-19 century, the German dye chemists 
were discovering that many plant, animal, and mine-
ral extracts colored various fabrics. As can be seen 
in many paintings, the variety of colors of dresses and 
garments increased remarkably during that period. 
Scientists realized that these same dyes could color 
the frustratingly transparent cells that they were trying 
to study. Thus the science of histology was born, and, 
almost as soon as scientists could see cells, they rea-
lized that some of the cells would die. In 1842, Karl Vogt, 
studying the metamorphosis of amphibians, realized 
that the notochord disappeared, and he indicated that 
the death of the notochord cells had to be physiological 
[1]. In 1864, August Weissman, also in metamorpho-
sis, pointed out the death of most cells in the pupae 
of insects [2]. He introduced the term “histolysis”, and 
described the appearance of dying cells. During the 
remainder of the 19th century, many other cells were ob-
served to die during normal development or metamor-
phosis: chondrocytes, cells in the ovarian follicle, post 
lactational mammary glands, myocytes and myofibrils, 
sensory neurons, and many others. Even Metchnikoff, 
looking at the number of phagocytes in the regressing 
muscles of the tadpole tail, pointed out that the muscles 
were in fact dying [3]. Throughout the first third of the 
20th century, there were many studies of cell death, 
mostly in embryos and metamorphosing animals. The 
first mention of cell death appears in the mid-19th C, 
with the writings of the great Walther Flemming [4], who 
described the involution of Graafian follicles in mam-
mals, followed by incidental reports by others on what 
appeared to be dying cells in the nervous system and 
elsewhere. In the beginning of the 20th C, a noticeable 
interest in metamorphosis of insects and amphibians, 
primarily in France, led to several publications, mar-
velous for their length and for their elaborate line and 
water-color drawings, particularly of the destruction 
of musculature and nervous system in insects and 
tadpoles at metamorphosis. Biologists like von Reck-
linghausen [5] had even clearly distinguished between 
oncosis, what we would today term necrosis, and the 
more physiological cell death that most commonly is de-
scribed as apoptosis. However, techniques were very 
limiting. Most cell deaths were observed in small tissues 
or animals, over a very short period of time, and only 
a small percentage of the cells could be dissected free. 
Thus the scientists at that time did not dare to hope that 
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they would be able to understand the causes or mecha-
nisms of the deaths that they observed.
Starting in the 1930s, the situation began to change. 
Victor Hamburger was exploring the mechanisms 
whereby tissues stimulated the growth of neurons [6] — 
the story that later would become the story of nerve 
growth factor. A few years later, he, together with Rita 
Levi-Montalcini, would clearly demonstrate that many 
neurons were born in each sensory ganglion, but in the 
absence of supporting tissue generating nerve growth 
factor, many of the neurons that were born would soon 
die [7]. Honor Fell, later Dame Honor Fell, began to exa-
mine in cell culture how chondrocytes died [8]. And 
John Saunders, recognizing specific patches of dying 
cells in chick embryos, wondered if he could dissect 
them free and study the control of their death [9]. 
Likewise, immunologists began to recognize that many 
thymocytes died in mammalian embryos, and even 
as the white blood cell count fell after an infection, this 
drop in white blood cells derived from the death of the 
circulating cells. In 1951, Alfred Glücksmann published 
a major review listing nearly 100 types of cell death 
during early vertebrate development [10]. Though his 
classifications are more focused on the purpose of the 
deaths, which today we would find not very helpful, 
he very effectively demonstrated that all cell death was 
a very normal aspect of development and homeostasis.
The 1950s bore witness to a major expansion in the 
technology of cell biology. Microscopy was ra pidly 
improving with the development and rapid growth 
of the capabilities of the phase contrast and electron 
microscopes, and the technology of homogenizing, 
osmotically protecting, and separating cell orga nelles 
by differential centrifugation was rapidly coming 
on board. Christian de Duve and his collaborators were 
examining the properties of mitochondria, which they 
could remove and purify by differential centrifugation. 
One enzyme that they considered to be mitochondrial 
was acid phosphatase. One night, they inadvertently left 
their samples on the desktop, rather than returning them 
to the refrigerator for storage overnight. They neverthe-
less tried to use their samples the next day and found, 
to their surprise, that the acid phosphatase activity was 
hugely increased. This led to their discovery of lyso-
somes and their exploration of the property of these 
organelles [11]. They learned that the lysosomes were 
distinct from the mitochondria and that they contained 
many acid hydrolases. Trying to discover the function 
of the lysosomes, they exposed rats to carbon tetra-
chloride, a known hepatotoxin, and looked at the effect 
on the lysosomes of the liver. They therefore proposed 
that the lysosomes were suicide bags, killing cells 
when they ruptured. We know today that this result was 
specific to carbon tetrachloride, since this lipid-soluble 
toxin directly attacks cell and lysosomal membranes. 
Nevertheless, it was the first hypothesis concerning 
the mechanism of cell death. As we describe below, 
this was one lead that we followed.
Meanwhile, John Saunders was becoming curious 
about the mechanisms by which cells died. He took 
cells from the axillae of embryonic chicken wings, which 
would die in the near future, and explanted them into 
tissue culture. They did well in the tissue culture until the 
time that they would have died in the embryo, at which 
time in culture they died. One could say that the cells 
were already moribund at the time he explanted them, 
but Saunders demonstrated that this was not true, for, 
when he transplanted them not to a culture dish but 
to the back of another embryo, they healed in and sur-
vived, contributing to the epidermis on the back of the 
host. Thus, as he would observe later, the cells were 
not already dying, but “the death clock was ticking” [9].
Personal comments RAL [“When I entered graduate 
school, my potential mentor, Carroll M. Williams, sug-
gested a series of possible projects to me. One was the 
fate of larval tissues during metamorphosis. Because 
he could store pupae in the refrigerator and take them 
out year around, he sugges ted that the death of the 
intersegmental muscles in the freshly emerged adult 
would be a non-season-limited tissue on which I could 
work. Since my undergraduate degree was in biochemi-
cal sciences, I considered that I could test the hypothesis 
of suicide bags. Howe ver, it is never a good idea for 
a graduate student to bet on only one horse — what 
if it doesn’t work? — and I elected to consider also neu-
rological and endocrine mechanisms, and to invest some 
time in looking at the tissues by electron microscopy. 
Briefly, what we learned was the following:
•	For the muscles to die, they needed to be potentia ted 
by the initial endocrine signal that led to the metamor-
phosis of the adults. If one interfered with that, one 
could also interfere with the death of the muscles [12].
•	As the development advanced and the insect ap-
proached ecdysis, the number of lysosomes in the 
tissue began to increase rapidly [13].
•	At the moment of emergence of the adult from its 
cocoon, there was a neural signal later (demon-
strated by Truman et al. [14] to be also neurose-
cretory) that triggered the conversion to the active 
phase of death. Chemically or surgically removing 
the neural activity led to the premature death of the 
muscles, while chemically or electrically driving the 
activity prevented the death of the muscles at the 
appointed time [15, 16].
•	Shortly after the activity of ecdysis ceased, there was 
a rapid expansion of the lysosomal system, includ-
ing the development of autophagic vacuoles and 
autophagosomes, and death became irreversible.
•	As we were to learn later, the events immediately 
surrounding ecdysis required synthesis of new 
messenger RNA and protein and could be blocked 
by administration of drugs that inhibited these pro-
cesses [17].
•	Also determined later, during the first 8 to 12 hours 
after ecdysis, the ensuing death was occult; the 
muscles were physiologically normal and could 
contract and respond normally. After 12 hours, 
by which time approximately ⅓ of the myofilaments 
had already been resorbed, the muscles rapidly 
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depolarized, became non-contractile, and were 
quickly resorbed [18].
Carroll Williams was always known for his colorful 
phraseology, and as graduate students we always tried 
to emulate him. Because computers were just begin-
ning to be talked about at the time, programmed cell 
death seemed to be a particularly modern and colorful 
way of describing what we saw. It was a metaphor sta-
ting what I thought was pretty obvious — if a biological 
process occurs at a defined location and time, then 
it must in some fashion be programmed or written into 
the genetics of the organism — but, as in poetry, meta-
phors help people see things that they otherwise would 
have not have noticed. Thus a relatively straightforward 
observation gained some currency”].
Meanwhile, with growing improvement in technical 
ability, many other laboratories beginning to investigate 
the mechanisms of cell death. To a very large extent, 
these studies focused on very appearance, number, 
and changes in morphology, of lysosomal bodies. 
In 1996 Jamshed Tata, exploiting the recent discovery 
that actinomycin D could inhibit the synthesis of pro-
teins, established that protein synthesis was required 
for the death of explants of tadpole tail [19]. Lockshin 
confirmed the findings for insect muscle [17], as did 
Munck and White [20] for find thymocytes exposed 
to glucocorticoids. Likewise, Oppenheim confirmed 
that protein synthesis was necessary for the death 
of neurons in chick embryos [21]. (This requirement 
later proved to be restricted to embryonic and other 
immature cells, as opposed to post mitotic or differen-
tiated cells, but the findings provoked more interest 
in the mechanisms of cell death.) Another paper that 
provoked some interest was that of Kerr, Wyllie, and 
Currie [22]. In this paper the authors drew on Kerr’s ear-
lier observations that “shrinkage necrosis” was com-
mon to most physiological forms of cell death [23] and 
that, unlike osmotic lysis in necrosis, there was no good 
mechanistic explanation of how it occurred, and they 
proposed that this type of cell death was the comple-
ment of mitosis, and suggested the name “apoptosis”. 
We were becoming more comfortable with the idea that 
death was not a random event, but rather a controlled 
event, for which mitosis was the compensation.
However, what really launched the field was a group 
of three scientific advances. Fittingly, each was of a dif-
ferent type: technical, conceptual, and theoretical.
The technical breakthrough was that in 1990, Arends 
and Wyllie, expanding Wyllie’s earlier interest in chro-
matin rearrangement in apoptosis, published a paper 
indicating that the simple technique of electrophoresing 
DNA could demonstrate apoptosis, since in necrotic 
cells randomly degraded DNA would produce a smear, 
whereas in apoptosis the DNA was cut in a more orderly 
fashion, between nucleosomes [24]. The technique 
and its expansion to more sensitive (labeling) versions 
was simple and cheap, enabling many laboratories 
to look for apoptosis. Spontaneous apoptosis hard 
to spot — the entire liver is replaced in approximately 
3 years, and an apoptotic cell may be identifiable for 
only 20 minutes, thereafter leaving no trace, whereas 
with appropriate labels a mitotic event may be traced 
years later. Even at the turnover rate of the liver, only 
one cell in 72.000 would be apoptotic at any time. Thus 
a technique that could reveal apoptosis allowed many 
researchers to observe apoptosis in many pathological 
and non-pathological (e.g., expansion and contraction 
of immunocompetent cells) situations, and to convince 
the research community of its importance.
The conceptual breakthrough was the recognition 
that several diseases, notably cancers, were associated 
with abnormal patterns of cell death. Thus in rapid suc-
cession B-cell lymphoma was recognized to be a failure 
of lymphocytes to die on time, deriving from the trans-
location of a gene that prevented cell death (Bcl-2) 
to a position of constitutive activation [25, 26]. The gene 
p53, known to be mutated in the majority of cancers, 
had been assumed to act by preventing mitosis of cells 
in which DNA had been damaged, but was now recog-
nized to provoke apoptosis if these cells had left G0 [27, 
28]. Finally, a cell surface protein, variously named Fas 
Ligand, Apo-1, and CD95, was recognized as capable 
of killing cells when linked to a soluble or cell-bound 
component [29, 30]. Peter Krammer displayed spec-
tacular pictures of tumor regression when the ligand was 
engaged. Ameisen [31] suggested that the devastation 
of AIDS was generated by the death of not seriously in-
fected bystander cells, which might be prevented. Thus 
cell death in general, and apoptosis in particular, were 
recognized as being important in medicine.
The theoretical breakthrough was the realization that 
the mechanism of cell death, and even the components 
of cell death, were conserved in evolution from nema-
tode worms to mammals. Thanks primarily to research 
coming from the laboratory of Horvitz and collaborators, 
the primary effector gene of apoptosis in worms, ced-3, 
was identified as a protease very similar to mammalian 
proteases, leading to the discovery of a new class 
of proteases (caspases) mostly associated with apop-
tosis [32]. The basic mechanism of control — all mature 
cells containing an inactive protease capable of kill-
ing the cell; the protease is activated by an activating 
molecule that interacts with it; and the activator is held 
in check by other molecules that normally suppress 
it — is common to worms and mammals. Even the com-
ponents are evolutionarily related: ced-3 to caspases, 
Bcl-2 to ced-9, and Apaf-1 to EGL-1. This conserva-
tion argues for a highly important biological role for 
cell death. The history is summarized in the Table. The 
basic pathways of apoptosis, summarized from many 
sources, are shown in Fig. 1, and the formal and mo-
lecular relationships of worm and mammalian apoptosis 
are illustrated in Fig. 2.
In the 21st century there have been many advances, 
too numerous to describe, and which have been 
reviewed in many other competent reviews. In brief, 
these can be summed into two categories: first, now 
that apoptosis is well understood, it has become pos-
sible and to recognize many other forms of cell death. 
Second, although we have considerable understanding 
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of the mechanisms of cell death, medical interventions 
based on this understanding has not been forthcoming.
The first category illustrates a common problem 
in the history of science: Although autophagy was con-
sidered a major mechanism of cell death in the 1970s, 
and was extensively studied, excitement over apopto-
sis led to the presumption that apoptosis was the only 
meaningful form of cell death. By the beginning of the 
21st century, it was apparent that not all forms of cell 
death represented classical apoptosis. There were 
of course the situations in which cells differentiated 
into nonviable forms, such as lens epithelium, keratino-
cytes, platelets, and erythrocytes. Several laboratories 
recognized that sometimes cells begin apoptosis but 
fail to complete it, since apoptosis require energy and 
it is possible to exhaust that energy before apoptosis 
is completed. Some forms of cell death were clearly 
programmed but more closely resembled necrosis and 
were given names such necroptosis and paraptosis. 
To some extent, the biology determined the situation: 
the normal fate of an apoptotic cell is to be phagocy-
tosed, but if phagocytes cannot reach the apoptotic 
cell, it may end in a form of necrosis. More problematic 
is the situation in insect metamorphosis. Although 
insect cells like those other animals can undergo 
apoptosis, in metamorphosis apoptosis is not seen. 
Instead, the cells undergo massive autophagy before 
fragmenting and being consumed by phagocytes. This 
situation obtains also for large mammalian cells with 
substantial cytoplasm, such as mammary epithelium 
in post lactational stage. Such situations gave rise 
to the concept of autophagic cell death.
65. Lizarbe Iracheta MA. El suicidio y la muerte cellular. Rev R Acad Cienc Exact Fis Nat 2007; 101: 1–33 (in Spanish).
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Fig. 1. Primary routes of apoptosis. Apoptosis may be initiated 
commonly by two routes: In the first (top) or extrinsic route an extra-
cellular molecule (Tumor Necrosis Factor — TNF) or Fas interacts with 
a membrane receptor, activating the Death Initiating Signaling Complex 
or DISC, which includes a defined sequence called the Death Domain 
(Fas-associated Death Domain FADD/TNF-Receptor with a Death 
Domain TRADD). In the complex an initiator caspase (cysteine protease 
hydroly zing at aspartic acid), caspase 8 or 10, is activated. This in turn 
activates an effector caspase, caspase 3, 6, or 7, which destroys many 
cytoplasmic proteins and, by entering the nucleus, destroys chromatin 
and nucleoplasmic proteins, permitting cleavage of DNA. In the second, 
or intrinsic, route, the initiator caspase may cleave Bid (BH3 interact-
ing domain death antagonist) to produce truncated Bid (t-Bid), which 
as a pro-death molecule, can compete with death antagonists at the 
mitochondrial outer membrane. Alternatively, metabolic conditions 
may also lead to the same mitochondrial outer membrane. In any 
event, the mitochondrion leaks cytochrome C, endonuclease G, and 
apoptosis-initiating factor (AIF) to the cytoplasm. In the cytoplasm, 
cytochrome C and AIF bind to and activate a multimeric complex termed 
the apoptosome, thus activating another initiator caspase, caspase 9. 
Caspase 9 then activates the same effector caspases
Fig. 2. Parallelism of Caenorhabditis and mammalian 
pathways of apoptosis. In these widely divergent creatures 
death is effected by a caspase. In mammals the effector cas-
pase is activated by initiator caspases. The caspase is activated 
through interaction with an adaptor, but the adaptor is normally 
held in check by a regulator. In certain cells at certain times, the 
normally-on regulator is blocked by a pro-death protein that 
releases the death pathway. The worm proteins Ced-9, Ced-4, 
and Ced-3 have not only formal but partial structural similarity 
to the corresponding mammalian genes
Today the situation for autophagy seems far more 
complex. Heavily stressed cells, such as those infected 
by with viruses, use autophagy as a defense mechanism. 
Those stressed cells that can undergo autophagy survive 
better than those that cannot. If we were to reassess the 
situation today, it would appear that autophagy is normally 
a defense mechanism that under some circumstances 
continues until all necessary resources of the cell are 
consumed and the cell finally dies. What controls the onset 
and limitation of autophagy, and why the cell does not initi-
ate apoptosis, are unknown and worthy of further study.
Finally, the reason that cell-death-based therapy 
is not yet available is becoming clear. For the most part, 
the origin of cell death based disease is not a failure 
of the mechanism of cell death — that is, of the caspas-
es or other controllers of death. The problem is normally 
the inappropriate activation or failure of activation of the 
cell death mechanism. Other than the case of B cell 
lymphoma, in which the Bcl-2 gene is translocated 
to a position in which it is constitutively active, the prob-
lem is not with the effectors themselves but rather the 
threshold at which cell death is activated. We do not yet 
understand what determines the threshold or sensitivity 
of the cell. Identifying and targeting these thresholds 
will ultimately produce cell death controlled therapy.
This essay has tried where possible to cite some 
of the originators of our current thinking in their original 
publications. Several histories have been published 
that give expanded or alternate views and are well 
worth reading in their own right. These reviews include 
those by Clarke and Clarke [62], Lockshin and Zakeri 
[63], Vaux [64], and Lizarbe Iracheta [65]. Some of the 
material in the tables and figures reflects observations 
originally made by these authors.
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